Task order #3, "continuous rodent and non-rodent pharmacokinetic assessments"
Ended Awarded Last action
- Contract number
- HHSN27100003
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,910,493
Award facts
- Opportunity
-
- TORFPNIHNINDS1707 Solicitation number
- Contract value 100% obligated
- $2,910,493.40 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,352 | |
| Supplemental Agreement for work within scope | $249,637 | |
| Funding Only Action | $0 | |
| Exercise an Option | $362,516 | |
| Supplemental Agreement for work within scope | $749,854 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $485,172 | |
| Funding Only Action | $380,674 | |
| Exercise an Option | $343,002 | |
| Original award | $338,286 |
About this award
The National Institute of Neurological Disorders and Stroke issued a delivery order to Sri International on September 30, 2017, under the Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ for continuous rodent and non-rodent pharmacokinetic assessments, with a ceiling value of $2.91 million.
Place of performance is Menlo Park, CA. The order's ultimate completion date is September 8, 2026. Pricing is cost-plus-fixed-fee with no set-aside applied.
Sri International is a non-profit research and development organization. SCI-reported labor activity across FY2020–FY2022 shows declining engagement: FY2021 captured $724 thousand invoiced across 1.8 FTEs and 3,703 contractor hours at a derived rate of $195.54 per hour, while FY2022 contracted to $591 thousand invoiced, 0.7 FTEs, and 1,446 contractor hours at $408.67 per hour. The rising hourly rate reflects a shift toward higher-skill labor composition. FY2022 data indicates no subcontractor participation; Sri International self-performed all reported hours.
Quick answers
Who was awarded contract HHSN27100003?
HHSN27100003 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2017.
How much is contract HHSN27100003 worth?
The government has obligated $2,910,493 on HHSN27100003.
Which agency awarded contract HHSN27100003?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN27100003, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract HHSN27100003 an order under another contract?
Yes. HHSN27100003 is a delivery order under HHSN271201600006I, an indefinite delivery contract, on Pharmacology and Toxicology for Therapeutics Program (PTTP).
Was contract HHSN27100003 competed?
The extent of competition for HHSN27100003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award